J D Kowalska1, C Oprea2,3, S de Witt3,4, A Pozniak3,5, D Gökengin6, M Youle3,7, J D Lundgren3,8,9, A Horban1,3. 1. Hospital for Infectious Diseases in Warsaw, Medical University of Warsaw, Warsaw, Poland. 2. Victor Babes Clinical Hospital for Infectious Diseases, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania. 3. European AIDS Clinical Society, Brussels, Belgium. 4. Infectious Diseases Department, Saint Pierre University Hospital Brussels, Brussels, Belgium. 5. Chelsea and Westminster Hospital, London, UK. 6. Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Ege University, Izmir, Turkey. 7. HIV Clinical Research, Royal Free Hospital, London, UK. 8. Department of Infectious Diseases, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. 9. Centre for Health and Infectious Disease Research (CHIP), Copenhagen, Denmark.
Abstract
OBJECTIVES: The objective of this paper is to summarize the outcomes of the Euroguidelines in Central and Eastern Europe (ECEE) conference held in Warsaw in February 2016. The main aim of this conference was to facilitate a discussion on European AIDS Clinical Society (EACS) guidelines implementation across the region and neighbouring countries and to present the current obstacles in benchmarking HIV care in Europe. METHODS: During a 2-day meeting, there were country-based presentations using a predefined template so as to make the data comparable and focus the discussion. Areas covered were country epidemiology, surveillance, national strategy for treatment and prevention, standards of care, access to care and treatment availability. Each participant filled in a questionnaire investigating HIV guidelines usage per country. RESULTS: In total, 16 Central and Eastern Europe (CEE) and neighbouring countries were represented at the conference: Albania, Armenia, Belarus, Croatia, Czech Republic, Estonia, Georgia, Hungary, Lithuania, Moldova, Poland, Romania, Russia, Serbia, Slovakia and Turkey. EACS guidelines version 7.1 were used in 14 (87%) countries. In 11 (69%) countries, national guidelines were available, of which eight had been recently updated. Half of the countries declared that they use World Health Organization (WHO) and Department of Health and Human Services (DHHS) guidelines, over one-third the European Centre for Disease Prevention and Control (ECDC) HIV testing guidelines and one in five the International Antiviral Society-USA (IAS-USA) Panel guidelines from 2012. CONCLUSIONS: Participants declared their will to promote the widespread use of EACS guidelines for HIV infection in the CEE region and neighbouring countries by signing the Warsaw Declaration. They also emphasized the need to increase publishing of data from national cohorts in that region.
OBJECTIVES: The objective of this paper is to summarize the outcomes of the Euroguidelines in Central and Eastern Europe (ECEE) conference held in Warsaw in February 2016. The main aim of this conference was to facilitate a discussion on European AIDS Clinical Society (EACS) guidelines implementation across the region and neighbouring countries and to present the current obstacles in benchmarking HIV care in Europe. METHODS: During a 2-day meeting, there were country-based presentations using a predefined template so as to make the data comparable and focus the discussion. Areas covered were country epidemiology, surveillance, national strategy for treatment and prevention, standards of care, access to care and treatment availability. Each participant filled in a questionnaire investigating HIV guidelines usage per country. RESULTS: In total, 16 Central and Eastern Europe (CEE) and neighbouring countries were represented at the conference: Albania, Armenia, Belarus, Croatia, Czech Republic, Estonia, Georgia, Hungary, Lithuania, Moldova, Poland, Romania, Russia, Serbia, Slovakia and Turkey. EACS guidelines version 7.1 were used in 14 (87%) countries. In 11 (69%) countries, national guidelines were available, of which eight had been recently updated. Half of the countries declared that they use World Health Organization (WHO) and Department of Health and Human Services (DHHS) guidelines, over one-third the European Centre for Disease Prevention and Control (ECDC) HIV testing guidelines and one in five the International Antiviral Society-USA (IAS-USA) Panel guidelines from 2012. CONCLUSIONS:Participants declared their will to promote the widespread use of EACS guidelines for HIV infection in the CEE region and neighbouring countries by signing the Warsaw Declaration. They also emphasized the need to increase publishing of data from national cohorts in that region.
Authors: Justyna D Kowalska; Grzegorz Wójcik; Jakub Rutkowski; Magdalena Ankiersztejn-Bartczak; Ewa Siewaszewicz Journal: PLoS One Date: 2017-11-13 Impact factor: 3.240
Authors: Agata Skrzat-Klapaczyńska; Justyna D Kowalska; Larisa Afonina; Svitlana Antonyak; Tatevik Balayan; Josip Begovac; Dominik Bursa; Gordana Dragovic; Deniz Gokengin; Arjan Harxhi; David Jilich; Kerstin Kase; Botond Lakatos; Mariana Mardarescu; Raimonda Matulionyte; Cristiana Oprea; Aleksandr Panteleev; Antonios Papadopoulos; Lubomir Sojak; Janez Tomazic; Anna Vassilenko; Marta Vasylyev; Antonija Verhaz; Nina Yancheva; Oleg Yurin; Andrzej Horban Journal: Int J Environ Res Public Health Date: 2022-06-21 Impact factor: 4.614
Authors: J D Kowalska; A Skrzat-Klapaczyńska; D Bursa; T Balayan; J Begovac; N Chkhartishvili; D Gokengin; A Harxhi; D Jilich; D Jevtovic; K Kase; B Lakatos; R Matulionyte; V Mulabdic; A Nagit; A Papadopoulos; M Stefanovic; A Vassilenko; M Vasylyev; N Yancheva; O Yurin; A Horban Journal: Int J Infect Dis Date: 2020-05-11 Impact factor: 3.623